Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Sep 14;26(8):1285-1294.
doi: 10.3727/096504018X15166193231711. Epub 2018 Jan 31.

Long Noncoding RNA GAS5 Promotes Proliferation, Migration, and Invasion by Regulation of miR-301a in Esophageal Cancer

Affiliations

Long Noncoding RNA GAS5 Promotes Proliferation, Migration, and Invasion by Regulation of miR-301a in Esophageal Cancer

Wei Li et al. Oncol Res. .

Retraction in

Abstract

Long noncoding RNA (lncRNA) growth arrest-specific transcript 5 (GAS5) has been revealed to be associated with the progression of various cancers. However, the biological roles of GAS5 in esophageal cancer (EC) remain unclear. We aimed to thoroughly explore the functions of GAS5 in EC. The results showed that GAS5 expression was increased in EC cells (ECA109, TE-1, TE-3, and EC9706) compared to SHEE cells. Knockdown of GAS5 decreased cell viability, migration, and invasion and induced apoptosis in EC9706 cells. Moreover, miR-301a appeared to be directly sponged by GAS5, and miR-301a suppression obviously alleviated the protumor effects of GAS5. Furthermore, miR-301a positively regulated CXCR4 expression, and overexpression of CXCR4 induced apoptosis and abolished the promoting effect of miR-301a inhibition on cell viability, migration, and invasion. Besides, miR-301a blocked Wnt/β-catenin and NF-κB signaling pathways by regulation of CXCR4. Our results indicated that GAS5 promoted proliferation and metastasis and inhibited apoptosis by regulation of miR-301a in EC. These data contributed to our understanding of the mechanisms of miRNA-lncRNA interaction and provides a novel therapeutic strategy for EC.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

Figure 1
Figure 1
Long noncoding RNA (lncRNA) growth arrest-specific transcript 5 (GAS5) was upregulated in esophageal cancer (EC) cells. Relative expressions of GAS5 in EC cell lines (ECA109, TE-1, TE-3, and EC9706) and in an esophageal epithelia cell line (SHEE) were detected by quantitative real-time reverse transcriptase (qRT)-PCR. All values are mean ± standard deviation (SD). Ns, no significance. *p < 0.05; **p < 0.01.
Figure 2
Figure 2
lncRNA GAS5 promoted proliferation and metastasis and inhibited apoptosis in EC cells. EC9706 cells were transfected with short hairpin (sh)-GAS5 #1 and sh-GAS5 #2 or negative control (sh-NC). (A) Relative expression of GAS5 was examined by qRT-PCR. (B) Cell viability, (C) migration, (D) invasion, and (E) apoptosis were determined by trypan blue exclusion, Transwell, and flow cytometry assays. (F, G) Expression of the main apoptosis factors was examined by Western blot. All values are mean ± SD. *p < 0.05; **p < 0.01; ***p < 0.001.
Figure 3
Figure 3
lncRNA GAS5 acted as a molecular sponge to regulate microRNA-301a (miR-301a) in EC. EC9706 cells were transfected with sh-GAS5 #2. (A) The combination of GAS5 and miR-301a was predicated by TargetScan, microRNA, and NCBI databases. (B) Relative expression of miR-301a was measured by qRT-PCR. (C) Relationship between miR-301a and GAS5 was detected by dual-luciferase reporter activity assay. All values are mean ± SD. **p < 0.01.
Figure 4
Figure 4
miR-301a mediated protumor effects of lncRNA GAS5 in EC cells. EC9706 cells were transfected with sh-GAS5, sh-GAS5 + miR-301a inhibitor, and corresponding controls. (A) Cell viability, (B) migration, (C) invasion, and (D) apoptosis were determined by trypan blue exclusion, Transwell, and flow cytometry assays. (E, F) Expression of the main apoptosis factors was examined by Western blot. All values are mean ± SD. *p < 0.05; **p < 0.01; ***p < 0.001.
Figure 5
Figure 5
miR-301a positively regulated chemokine C-X-C motif receptor 4 (CXCR4) expression. EC9706 cells were transfected with miR-301a mimic, inhibitor, and corresponding controls. (A) Relative mRNA expression of CXCR4 was detected by qRT-PCR. (B, C) Relative protein level of CXCR4 was detected by Western blot assay. All values are mean ± SD. **p < 0.01; ***p < 0.001.
Figure 6
Figure 6
miR-301a suppression promoted cell proliferation and metastasis and inhibited apoptosis by regulating CXCR4. EC9706 cells were transfected with miR-301a mimic, miR-301a inhibitor, pEX-CXCR4, sh-CXCR4, and corresponding controls. (A) The protein level of CXCR4 was detected by Western blot. (B, C) Relative expression of CXCR4 was examined by qRT-PCR and Western blot. (D) Cell viability, (E) migration, (F) invasion, and (G) apoptosis were determined by trypan blue exclusion, Transwell, and flow cytometry assays. (H, I) The expression of the main apoptosis factors was examined by Western blot. All values are mean ± SD. *p < 0.05; **p < 0.01; ***p < 0.001.
Figure 7
Figure 7
miR-301a blocked the Wnt/β-catenin and nuclear factor κ B (NF-κB) signaling pathways by regulation of CXCR4. EC9706 cells were transfected with miR-301a mimic, miR-301a inhibitor, miR-301a inhibitor + sh-CXCR4, and corresponding controls. Relative protein levels of the (A, B) Wnt/β-catenin signal pathway and (C, D) NF-κB signal pathway were examined by Western blot. All values are mean ± SD. *p < 0.05; **p < 0.01; ***p < 0.001.

Similar articles

Cited by

References

    1. Cools-Lartigue J, Spicer J, Ferri LE. Current status of management of malignant disease: Current management of esophageal cancer. J Gastrointest Surg. 2015;19(5):964–72. - PubMed
    1. Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, Abraham J, Adair T, Aggarwal R, Ahn SY, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: A systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012;380(9859):2095–128. - PMC - PubMed
    1. Mir MR, Rajabpour MV, Delarestaghi MM, Hadji M, Harirchi I, Mir P, Mir A, Lashkari M, Zendehdel K. Short- and long-term survival of esophageal cancer patients treated at the Cancer Institute of Iran. Dig Surg. 2013;30(4–5):331–6. - PubMed
    1. Aghajanzadeh M, Rahimi A, Emami D, Aghajanzadeh G, Jahromi SK, Ebrahimi H. A comparison of survival with chemoradiation therapy alone versus surgery and post-esophagectomy chemoradiation in patients with esophageal carcinoma. Nishinihon J Urol. 2014;2(4):350–2.
    1. Huang C, Cao L, Qiu L, Dai X, Ma L, Zhou Y, Li H, Gao M, Li W, Zhang Q. Upregulation of H19 promotes invasion and induces epithelial-to-mesenchymal transition in esophageal cancer. Oncol Lett. 2015;10(1):291–6. - PMC - PubMed

Publication types

LinkOut - more resources